What Is Keratoconus Eye Disease? Symptoms & Treatment

Keratoconus is a progressive eye condition in which the cornea, the clear front surface of the eye, gradually thins and bulges outward into a cone-like shape. It affects roughly 1 in 350 people worldwide, typically appears during the teenage years, and worsens over time before stabilizing in most people by their 30s or 40s. The irregular corneal shape distorts light entering the eye, causing blurred and warped vision that glasses alone often can’t fully correct.

What Happens Inside the Cornea

A healthy cornea holds its dome shape because layers of collagen fibers are tightly woven together and anchored in place by a kind of molecular glue: a mix of proteins, proteoglycans, and bridging collagen that keeps everything cohesive. In keratoconus, that glue weakens. The collagen layers start to slip apart and unravel, particularly at points where they branch or connect to deeper structures. This slippage thins the central cornea and changes its curvature without necessarily destroying the collagen itself.

There’s also evidence of actual tissue breakdown. Studies have found increased activity of degradative enzymes in keratoconus corneas, along with focal damage to Bowman’s layer, a thin protective sheet just beneath the surface. These two processes, slippage and degradation, likely work together. Enzymatic breakdown weakens the bonds between collagen fibers, which then allows them to slide and redistribute, thinning the center of the cornea and pushing it forward into its characteristic cone shape.

How Keratoconus Affects Vision

The cone shape scatters light unevenly across the retina, producing visual distortions that go well beyond simple blurriness. People with keratoconus commonly see ghosting or multiple overlapping images from a single light source, a phenomenon called monocular polyopia. Bright lights develop halos and streaks, making night driving particularly difficult. Sensitivity to light and glare increases as the disease progresses.

In early stages, keratoconus often looks like ordinary nearsightedness or astigmatism, and many people go through several glasses prescriptions before anyone suspects something more is going on. A hallmark clue is astigmatism that keeps shifting or worsening, especially during the late teens and twenties. If your eye doctor keeps changing your prescription and your vision still isn’t crisp, keratoconus is one of the conditions they should rule out.

Who Gets It and Why

Keratoconus typically first appears during puberty, progresses through the teens and twenties, and usually stabilizes in the third or fourth decade of life. That natural stabilization happens partly because the cornea undergoes its own slow, low-level cross-linking over the years as a byproduct of normal cellular metabolism.

Most cases are not inherited and occur in people with no family history of the condition. Still, genetics plays some role: having a first-degree relative with keratoconus does raise your risk. Vigorous, habitual eye rubbing is one of the most discussed modifiable risk factors, though the relationship is complicated. It’s unclear whether rubbing triggers the disease or whether people rub because their eyes are already irritated in the early, undiagnosed stages. Either way, chronic eye rubbing likely accelerates thinning in a cornea already predisposed to the condition. Keratoconus is also more common in people with allergic eye disease, Down syndrome, and connective tissue disorders like Ehlers-Danlos syndrome.

How It’s Diagnosed

A standard eye exam can suggest keratoconus, but confirming it requires corneal topography, a painless imaging scan that maps the shape of the cornea in detail. The test produces a color-coded map showing steep and flat zones. Doctors look for several specific markers: a central corneal curvature steeper than about 48.7 diopters, an asymmetry between the upper and lower halves of the cornea greater than 1.2 diopters, astigmatism above 2.5 diopters, and elevated posterior (back surface) measurements above 18 to 20 microns. Milder, subclinical cases sometimes fall into an intermediate range and require repeat mapping over time to confirm progression.

Some clinics also measure corneal thickness directly. A keratoconus cornea is typically thinner than normal at its steepest point, sometimes significantly so. Combining topography with thickness measurements and posterior elevation data gives the most complete picture of severity and helps guide treatment decisions.

Managing Vision With Contact Lenses

Glasses work fine in the earliest stages, but as the cornea becomes more irregular, standard lenses can’t compensate for the distorted surface. Rigid gas-permeable contact lenses are often the next step. These hard lenses create a smooth optical surface in front of the irregular cornea, allowing light to focus more cleanly on the retina.

For more advanced cases or people who can’t tolerate standard rigid lenses, scleral lenses are a major advancement. These larger-diameter lenses vault entirely over the cornea and rest on the white part of the eye (the sclera), creating a fluid-filled space between the lens and the corneal surface. This design neutralizes the irregularities of the cone and delivers sharper, more stable vision than glasses or soft contacts can achieve. Many patients experience a dramatic improvement when switching to scleral lenses. They’re also more comfortable than smaller rigid lenses for most wearers because the edges don’t interact with the sensitive corneal surface.

Corneal Cross-Linking: Stopping Progression

Corneal collagen cross-linking (CXL) is the only treatment that targets the underlying disease process rather than just correcting the vision it causes. The procedure strengthens the bonds between collagen fibers, stiffening the cornea to prevent further thinning and bulging. It has a success rate of around 95% for halting progression.

During the procedure, riboflavin (vitamin B2) eye drops are applied to the cornea and allowed to soak in for about 30 minutes. Then a focused beam of ultraviolet light is directed onto the cornea for another 30 minutes. The combination triggers chemical reactions that form new bonds between collagen fibers, essentially doing in one session what the body does naturally over decades. Recovery involves a few days of discomfort and light sensitivity, with vision gradually improving over weeks to months. Cross-linking doesn’t reverse keratoconus or eliminate the need for corrective lenses in most cases, but it can stop the disease in its tracks. It’s most valuable for younger patients whose corneas are still actively changing.

When a Corneal Transplant Is Needed

A small percentage of people with keratoconus progress to a point where contact lenses can no longer provide usable vision, or where the cornea develops significant scarring. In these cases, a corneal transplant may be recommended. The good news is that keratoconus has the best transplant outcomes of any corneal condition. Five-year graft survival rates reach 97%, and at ten years the figure is still 92%.

The most common transplant approach replaces the full thickness of the central cornea with donor tissue. Recovery is gradual, often taking a year or more for vision to fully stabilize, and most people still need glasses or contact lenses afterward. Newer partial-thickness techniques that replace only the front layers of the cornea are becoming more common and can offer faster healing with lower rejection risk. Transplant remains a last resort, though, reserved for the minority of patients who don’t respond well to lenses and cross-linking.

Living With Keratoconus

For most people, keratoconus is a manageable condition rather than a devastating one. The majority maintain good functional vision with the right lenses, and cross-linking has dramatically reduced the number of patients who eventually need surgery. The key is early detection. If you’re in your teens or twenties with rapidly shifting prescriptions, persistent astigmatism, or visual distortions that glasses don’t fix, ask for a corneal topography scan. Catching the disease while it’s still mild opens the door to cross-linking before significant damage occurs, and makes the long-term outlook considerably better.

Avoiding vigorous eye rubbing is one practical step anyone at risk can take. If allergies or dry eyes are driving the urge to rub, treating the underlying irritation with preservative-free artificial tears or allergy drops removes the temptation and may help protect a vulnerable cornea.